Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/27/2012CN101547920B Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound
06/27/2012CN101535280B Arylsulfonamide compounds
06/27/2012CN101516860B Benzoxazoles and oxazolopyridines being useful as FANUS kinases inhibitors
06/27/2012CN101506162B Substituted isoindoles as bace inhibitors and their use
06/27/2012CN101503399B C-aryl glucoside SGLT2 inhibitor
06/27/2012CN101502326B Method for preparing vitamin E nano liposome
06/27/2012CN101501002B Non-nucleoside reverse transcriptase inhibitors
06/27/2012CN101500554B Sulfonamide compound or salt thereof
06/27/2012CN101485885B Protein phosphatase PPM1E used as target for treating disease as well as use thereof and siRNA
06/27/2012CN101485687B Medicament for treating gastrointestinal tract disease using biological viable bacteria
06/27/2012CN101479288B Improved treatment of cystic fibrosis
06/27/2012CN101474195B Medicament composition for treating cardiac and cerebral vascular disease
06/27/2012CN101468058B Tiangua tinea and bacterium eliminating agent for treating dermatopathy and preparation method thereof
06/27/2012CN101466695B New chiral intermediate, process for rpoducing the same and its use in the manufacture of tolerodine, fesoterodine, or the active metabolitte thereof
06/27/2012CN101463060B 通关藤提取物 Marsdenia extract
06/27/2012CN101454319B Novel heterocyclic compound or salt thereof and intermediate thereof
06/27/2012CN101454285B Oxadiazole derivatives as comt inhibitors
06/27/2012CN101450091B Purification method of Panax notoginseng saponins
06/27/2012CN101448835B 6,7,8, 9 -tetrahydro- 5h- pyrimido [4, 5-d] azepin-4-yl] -amine derivatives as modulators of trpvl for the treatment of pain
06/27/2012CN101444526B Pharmaceutical composition
06/27/2012CN101439077B Medicament containing dalbergia heartwood for treating blood vessel endothelium dysfunction and preparation method thereof
06/27/2012CN101439050B Medicament for treating malignancy and production method
06/27/2012CN101433329B Nutritive composition with health-care function
06/27/2012CN101397274B Novel natural imidazole formic acid derivates, preparation method and use thereof
06/27/2012CN101384565B Substituted oxadiazole derivatives and their use as opioid receptor ligands
06/27/2012CN101384563B Substituted oxazole derivatives with an analgesic action
06/27/2012CN101375927B Pharmaceutical combination for preventing birth-defect and improving memory
06/27/2012CN101374833B Novel pyrone-indole derivatives and process for their preparation
06/27/2012CN101366831B Rhubarb polyoses, preparation method, medicament composition and uses
06/27/2012CN101366772B Medicament composition for preventing birth defection and improving memory
06/27/2012CN101361707B Vaginal suppository for exterminating AIDS virus and sperm
06/27/2012CN101353339B Synthesis of quercetin platinum
06/27/2012CN101352418B Pirarubicin or pirarubicin hydrochloride lipid nano granule and preparation method thereof
06/27/2012CN101333196B 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
06/27/2012CN101307088B Method for preparing cholic acid conjugates
06/27/2012CN101291934B Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
06/27/2012CN101291650B Anti-inflammatory compositions and methods of use
06/27/2012CN101254248B Applications of Chinese medicinal composition for preparing medicament for curing chronic fatigue syndrome medicament
06/27/2012CN101242833B Pyrrolopyridine derivatives and use of same as PPAR receptor modulators
06/27/2012CN101218232B Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
06/27/2012CN101180319B Aldehyde conjugated flavonoid preparations
06/27/2012CN101133038B HIV inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines
06/27/2012CN101103022B New carboxylic acid amide used as XA inhititor
06/27/2012CN101077350B Compostion and method of treating gonad dysfunction
06/27/2012CN101066340B Compound externally applied tetrodotoxin ointment and its prepn
06/27/2012CN101032562B Health care product having functions of conditioning blood pressure and protecting haemal system of heart and brain
06/26/2012USRE43497 Anti-MIF antibodies
06/26/2012US8209131 Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules
06/26/2012US8207381 1-Bromo-1,1-difluoro-non-2-yn-4-ol; 6-Bromo-6,6-difluoro-2,2-dimethyl-hex-4-yn-3-ol; anticarcinogenic, -tumor, -metastasic agents; enzyme inhibitors of modification methylases; myelodysplastic syndrome, leukemia, a solid tumor, schizophrenia, sickle cell disease, or lupus; breast, colon, brain cancers
06/26/2012US8207380 Reacting hydroxyaromatic compound polypropylene in presence of acid catalyst; lubricating oils
06/26/2012US8207363 Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
06/26/2012US8207361 Tigecycline crystalline forms and processes for preparation thereof
06/26/2012US8207350 Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
06/26/2012US8207347 Pyridone derivatives as NK3 antagonists
06/26/2012US8207346 Methods of synthesizing anatabine
06/26/2012US8207344 GPR119 agonists
06/26/2012US8207340 Imidazopyridinyl benzamide mitotic kinesin inhibitors
06/26/2012US8207338 Phosphonic acid compounds as inhibitors of serine proteases
06/26/2012US8207313 Natural products from Vinca
06/26/2012US8207262 Hydroxyphenyl cross-linked macromolecular network and applications thereof
06/26/2012US8207230 Functional role for cannabinoids in autonomic stability during sleep
06/26/2012US8207229 Preparation of hydroquinone amide compounds with antioxidant properties
06/26/2012US8207228 Calixarene-based peptide conformation mimetics, methods of use, and methods of making
06/26/2012US8207227 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
06/26/2012US8207226 Use of FAAH antagonists for treating dry eye and ocular pain
06/26/2012US8207225 Fatty ester food adjuvant; animal feeds; controlling oxidation to volatile organic compounds; storage stability; oxidation resistance
06/26/2012US8207224 Preservatives based on carboxylic anhydrides
06/26/2012US8207223 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient
06/26/2012US8207222 Nitric oxide releasing derivatives of paracetamol
06/26/2012US8207221 Crystalline polymorphs of a CXC-chemokine receptor ligand
06/26/2012US8207220 Substituted benzothiazoles as orexin antagonists
06/26/2012US8207219 Ion channel modulating activity I
06/26/2012US8207218 DMAE as sole agent for the treatment of mild cognitive impairment
06/26/2012US8207217 Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan
06/26/2012US8207216 Benzofuran-3-yl(indol-3-yl) maleimides as potent GSK3 inhibitors
06/26/2012US8207215 Ketorolac tromethamine compositions for treating or preventing ocular pain
06/26/2012US8207214 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
06/26/2012US8207213 Benzoisoindole derivatives for the treatment of pain
06/26/2012US8207212 Methods and devices for epithelial protection during photodynamic therapy
06/26/2012US8207211 Photosensitizers for targeted photodynamic therapy
06/26/2012US8207210 Aminoindazolylurea derivatives
06/26/2012US8207209 Methods of inhibiting viral infection
06/26/2012US8207208 Angiotensin II receptor antagonists
06/26/2012US8207206 (S,R)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent
06/26/2012US8207205 Compounds, compositions and methods comprising oxadiazole derivatives
06/26/2012US8207204 Triazole derivatives as SCD inhibitors
06/26/2012US8207203 Pyridylisoxazole derivatives
06/26/2012US8207202 N-(2-aminophenyl)-4-{1-[(5-methoxy-1,3-dimethyl-1H-pyrazol-4-yl)methyl]piperidin-4-yl}benzamide, for example; use as an antiproliferative agent in the prevention or treatment of tumors or other proliferative conditions, which are sensitive to the inhibition of histone deacetylase
06/26/2012US8207201 Agent for prophylaxis or treatment of alcohol dependence or drug dependence
06/26/2012US8207200 Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione follow by autologous stem cell transplantation
06/26/2012US8207199 Azole compound
06/26/2012US8207198 Substituted triazole derivatives as oxytocin antagonists
06/26/2012US8207197 to treat psychosomatic disorders, respiratory, allergic conditions, inflammatory conditions, cardiac conditions, gastrointestinal conditions, conditions of the urogenital system, and conditions of the cutaneous system
06/26/2012US8207196 Compositions and methods for the treatment of metabolic disorders
06/26/2012US8207195 Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds
06/26/2012US8207194 Compounds having a 4-pyridylalkylthio group as a substituent
06/26/2012US8207193 Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists
06/26/2012US8207192 Quinuclidine compounds having quaternary ammonium group, its preparation method and use as blocking agents of acetylcholine
06/26/2012US8207191 Process, salts, composition and use
06/26/2012US8207190 Enantiomer of tenatoprazole and the use thereof in therapy
1 ... 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 ... 7860